nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Syncope—Triamcinolone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Guanabenz—Syncope—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Guanabenz—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Guanabenz—Oedema—Prednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Guanabenz—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Guanabenz—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Guanabenz—Shock—Prednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Guanabenz—Cough—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Guanabenz—Tachycardia—Prednisolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Guanabenz—Hypertension—Triamcinolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Guanabenz—Hypertension—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Guanabenz—Myalgia—Triamcinolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Guanabenz—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Guanabenz—Myalgia—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Guanabenz—Eye disorder—Prednisone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Guanabenz—Anxiety—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Guanabenz—Infestation NOS—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Guanabenz—Infestation—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Guanabenz—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Guanabenz—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Guanabenz—Discomfort—Triamcinolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Guanabenz—Discomfort—Methylprednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Guanabenz—Dry mouth—Triamcinolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Guanabenz—Angioedema—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Guanabenz—Angioedema—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Guanabenz—Confusional state—Methylprednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Guanabenz—Immune system disorder—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Guanabenz—Malaise—Betamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Guanabenz—Malaise—Dexamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Guanabenz—Oedema—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Guanabenz—Syncope—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Guanabenz—Syncope—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Guanabenz—Infection—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Guanabenz—Infection—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Guanabenz—Shock—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Guanabenz—Shock—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Guanabenz—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Guanabenz—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Guanabenz—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Guanabenz—Paraesthesia—Prednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Guanabenz—Tachycardia—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Guanabenz—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Guanabenz—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Guanabenz—Erythema—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Guanabenz—Malnutrition—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Guanabenz—Hypertension—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Guanabenz—Hypertension—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Guanabenz—Myalgia—Dexamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Guanabenz—Myalgia—Betamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Guanabenz—Anxiety—Betamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Guanabenz—Anxiety—Dexamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Guanabenz—Discomfort—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Guanabenz—Discomfort—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Guanabenz—Haemoglobin—Methotrexate—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Guanabenz—Hypotension—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Guanabenz—Pain—Prednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Guanabenz—Haemorrhage—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Guanabenz—Vision blurred—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Guanabenz—Oedema—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Guanabenz—Oedema—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Guanabenz—Infection—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Guanabenz—Infection—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Guanabenz—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Guanabenz—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Guanabenz—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Guanabenz—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Guanabenz—Anaemia—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Guanabenz—Shock—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Guanabenz—Shock—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Guanabenz—Dyspnoea—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Guanabenz—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Agitation—Prednisone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Tachycardia—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Tachycardia—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Guanabenz—Angioedema—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Guanabenz—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Guanabenz—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Guanabenz—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Guanabenz—Malaise—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Guanabenz—Eye disorder—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Guanabenz—Syncope—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Guanabenz—Tinnitus—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Guanabenz—Anorexia—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Guanabenz—Anorexia—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Guanabenz—Urticaria—Prednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Guanabenz—Fatigue—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Guanabenz—Fatigue—Methylprednisolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Guanabenz—Pain—Triamcinolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Guanabenz—Loss of consciousness—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Guanabenz—Hypotension—Dexamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Guanabenz—Hypotension—Betamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Guanabenz—Immune system disorder—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Guanabenz—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Guanabenz—Hypertension—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Guanabenz—Chills—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Guanabenz—Arthralgia—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Guanabenz—Myalgia—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Guanabenz—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Guanabenz—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Guanabenz—Anxiety—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Guanabenz—Paraesthesia—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Guanabenz—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Guanabenz—Discomfort—Prednisone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Guanabenz—Malnutrition—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Guanabenz—Erythema—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Guanabenz—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Guanabenz—Dyspepsia—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Guanabenz—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Guanabenz—Urticaria—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Guanabenz—Urticaria—Methylprednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Guanabenz—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Guanabenz—Oedema—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Guanabenz—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Guanabenz—Decreased appetite—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Guanabenz—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Guanabenz—Infection—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Guanabenz—Back pain—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Guanabenz—Fatigue—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Guanabenz—Fatigue—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Guanabenz—Shock—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Guanabenz—Pain—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Guanabenz—Pain—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Guanabenz—Nervous system disorder—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Guanabenz—Tachycardia—Prednisone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Guanabenz—Skin disorder—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Guanabenz—Vision blurred—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Guanabenz—Anorexia—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Guanabenz—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Guanabenz—Anaemia—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Guanabenz—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Guanabenz—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Guanabenz—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Guanabenz—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Guanabenz—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Guanabenz—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Guanabenz—Malaise—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Guanabenz—Leukopenia—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Guanabenz—Urticaria—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Guanabenz—Urticaria—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Guanabenz—Dizziness—Prednisolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Guanabenz—Asthenia—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Guanabenz—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Guanabenz—Body temperature increased—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Guanabenz—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Guanabenz—Abdominal pain—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Guanabenz—Asthenia—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Guanabenz—Paraesthesia—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Guanabenz—Pruritus—Triamcinolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Guanabenz—Cough—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Guanabenz—Pruritus—Methylprednisolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Guanabenz—Dyspepsia—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Guanabenz—Chest pain—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Guanabenz—Arthralgia—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Guanabenz—Myalgia—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Guanabenz—Decreased appetite—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Guanabenz—Rash—Prednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Guanabenz—Dermatitis—Prednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Guanabenz—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Guanabenz—Fatigue—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Guanabenz—Headache—Prednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Guanabenz—Discomfort—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Guanabenz—Constipation—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Guanabenz—Confusional state—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Guanabenz—Dizziness—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Guanabenz—Dizziness—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Guanabenz—Infection—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Guanabenz—Feeling abnormal—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Guanabenz—Asthenia—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Guanabenz—Asthenia—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Guanabenz—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Guanabenz—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Guanabenz—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Guanabenz—Nausea—Prednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Guanabenz—Pruritus—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Guanabenz—Pruritus—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Guanabenz—Skin disorder—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Guanabenz—Vomiting—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Guanabenz—Vomiting—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Guanabenz—Rash—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Guanabenz—Dermatitis—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Guanabenz—Anorexia—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Guanabenz—Rash—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Guanabenz—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Guanabenz—Urticaria—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Guanabenz—Headache—Triamcinolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Guanabenz—Headache—Methylprednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Guanabenz—Abdominal pain—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Guanabenz—Body temperature increased—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Guanabenz—Diarrhoea—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Guanabenz—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Guanabenz—Hypotension—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Guanabenz—Dizziness—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Guanabenz—Dizziness—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Guanabenz—Nausea—Triamcinolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Guanabenz—Paraesthesia—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Guanabenz—Nausea—Methylprednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Guanabenz—Dyspnoea—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Guanabenz—Hypersensitivity—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Guanabenz—Dyspepsia—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Guanabenz—Vomiting—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Guanabenz—Vomiting—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Guanabenz—Decreased appetite—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Guanabenz—Rash—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Rash—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Dermatitis—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Dermatitis—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Fatigue—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Headache—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Headache—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Asthenia—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Guanabenz—Pain—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Guanabenz—Pruritus—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Guanabenz—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Guanabenz—Diarrhoea—Prednisone—psoriatic arthritis	0.000968	0.000968	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Guanabenz—Nausea—Betamethasone—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Guanabenz—Nausea—Dexamethasone—psoriatic arthritis	0.000965	0.000965	CcSEcCtD
Guanabenz—Urticaria—Methotrexate—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Guanabenz—Dizziness—Prednisone—psoriatic arthritis	0.000936	0.000936	CcSEcCtD
Guanabenz—Body temperature increased—Methotrexate—psoriatic arthritis	0.000935	0.000935	CcSEcCtD
Guanabenz—Abdominal pain—Methotrexate—psoriatic arthritis	0.000935	0.000935	CcSEcCtD
Guanabenz—Vomiting—Prednisone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Guanabenz—Rash—Prednisone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Guanabenz—Dermatitis—Prednisone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Guanabenz—Headache—Prednisone—psoriatic arthritis	0.000887	0.000887	CcSEcCtD
Guanabenz—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000871	0.000871	CcSEcCtD
Guanabenz—Asthenia—Methotrexate—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Guanabenz—Nausea—Prednisone—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Guanabenz—Pruritus—Methotrexate—psoriatic arthritis	0.000837	0.000837	CcSEcCtD
Guanabenz—Diarrhoea—Methotrexate—psoriatic arthritis	0.000809	0.000809	CcSEcCtD
Guanabenz—Dizziness—Methotrexate—psoriatic arthritis	0.000782	0.000782	CcSEcCtD
Guanabenz—Vomiting—Methotrexate—psoriatic arthritis	0.000752	0.000752	CcSEcCtD
Guanabenz—Rash—Methotrexate—psoriatic arthritis	0.000746	0.000746	CcSEcCtD
Guanabenz—Dermatitis—Methotrexate—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Guanabenz—Headache—Methotrexate—psoriatic arthritis	0.000741	0.000741	CcSEcCtD
Guanabenz—Nausea—Methotrexate—psoriatic arthritis	0.000703	0.000703	CcSEcCtD
